The Campus · Kinesiology

The WalkBack trial: a walking program cut back-pain recurrence by a quarter

In a Lancet randomised trial of 701 adults recovered from a back-pain episode, an individualised progressive walking-plus-education program cut recurrence risk by 28% and nearly doubled the median pain-free interval — 208 days versus 112.

Most back-pain episodes settle — and then most of them come back. Preventing recurrence is arguably the highest-value problem in low back pain, and the WalkBack trial attacked it with the least glamorous tool available: walking.

Seven hundred and one Australian adults who had just recovered from an episode of non-specific low back pain were randomised to either no intervention or an individualised, progressive walking program with physiotherapist-guided education — six sessions across six months, building toward five walks a week of about 30 minutes.

The results earned their Lancet publication. Recurrence risk fell by 28% (hazard ratio 0.72), and the median time to a recurrence nearly doubled, from 112 days to 208. The program was also cheap enough to be clearly cost-effective — AU$7,802 per quality-adjusted life year, with 94% probability of cost-effectiveness.

The honest footnotes: neither participants nor their physiotherapists could be blinded, which can inflate self-reported outcomes, and the walkers logged more minor lower-limb complaints along the way (100 versus 54 events) — walking is safe and cheap, but not entirely effort- or niggle-free.

The deeper message aligns with everything modern back-pain science says: the spine responds to regular, progressive, unthreatening load. It does not require special equipment — it requires a structured program, a coach who progresses it, and the education to stop fearing normal movement.

Key findings

  • 701 adults recently recovered from an episode of non-specific low back pain, randomised to the program or no intervention.
  • Walking plus education reduced recurrence risk: hazard ratio 0.72 (95% CI 0.60–0.85, p = 0.0002).
  • Median time to recurrence nearly doubled: 208 days versus 112 days.
  • Cost-effective at AU$7,802 per quality-adjusted life year (94% probability of cost-effectiveness).
  • Participants and physiotherapists were unblinded, and the walking group logged more minor lower-limb complaints (100 vs 54 events).

Clinical relevance

For clients who ask how to keep back pain from returning after we finish a rehab block, this is the answer with a Lancet trial behind it: a progressive, coached walking habit. It is also why our kinesiology programs end with a maintenance plan rather than a goodbye.

This research in practice

The Volt Health services where this evidence is applied

Connected research

Read alongside this article

Articles that reference this one

Source

This article paraphrases the following peer-reviewed publication. Review the original for full methodology and results:

Pocovi NC, Lin CC, French SD, et al. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial. Lancet. 2024.

Prepared by the Volt Health team as an educational summary of the cited publication. It is not medical advice; assessment and treatment decisions should always be made with a qualified health professional.

Discussion

No comments yet — be the first to share your thoughts.

Comments are public and moderated. Please don't include personal health details.

Cookies & Privacy

We use cookies to make your experience on the site better and to understand how visitors use it. To comply with applicable regulation, we ask for your consent to set these cookies. No personal information is collected.